Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, ...

Bluejay Diagnostics, Inc. (NASDAQ: BJDX), today announced acceptance of an abstract related to the Symphony IL-6 Test, the company’s lead product candidate, for presentation at the Society of Academic ...

The abstract should be written in 250 words or less (not including title, authors, and department). Involve your mentor at each stage of the process, from idea to final presentation. Your mentor will ...

Details of the accepted abstracts are as follows ... or the negative or plural of these words or similar expressions. Examples of such forward-looking statements include but are not limited ...

Submit a maximum of 3-page, 12-point font abstract detailing the theoretical background, methodology and findings (The use of the style template from our website is ...

and major contact person in the abstract submission form and indicate student competition presentation in the presentation preference. All students' competition presentations will be held in parallel ...

today announced an abstract on AFM24 dose optimization using exposure response analysis has been accepted for presentation as a poster at the Annual Meeting of the American Association for Cancer ...

1. Must include a title slide consistent with the submitted abstract. 2. If multiple authors, only one may be present. 3. Limited to 10 minutes. 1. Poster guidelines for in-person and virtual ...

Additional meeting information can be found on the AACR website: https://www.aacr.org/meeting/aacr-annual-meeting-2024/abstracts/ The abstract and poster will also be ...

Back in 2017, we reported that architect Michael Anderson was restoring a circa 1892 building at 313 Broadway, which he was using as his headquarters for his firm, Abstract Architecture.